---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-039510"
form_type: "8-K"
ticker: "IONS"
cik: "0000874015"
company_name: "IONIS PHARMACEUTICALS INC"
filed_at: "2021-11-26T23:59:59+00:00"
generated_at: "2026-06-28T05:22:56.369977+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director Peter Reikes resigns from Ionis board to join FDA, effective Nov 21, 2021

## Summary
- Peter N. Reikes resigned from the Board of Directors effective November 21, 2021.
- Resignation due to accepting a position with the U.S. Food and Drug Administration to avoid a perception of conflict of interest.
- No successor has been named to fill the vacancy on the Board.
- Company expressed gratitude for Reikes' advice and leadership as a Board member.

## SEC filing metadata
- accession: 0001140361-21-039510
- form_type: 8-K
- ticker: IONS
- cik: 0000874015
- company_name: IONIS PHARMACEUTICALS INC
- filed_at: 2021-11-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/0001140361-21-039510-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/brhc10031117_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-039510
- JSON: https://secwatch.observer/filing/0001140361-21-039510.json
- Plain text: https://secwatch.observer/filing/0001140361-21-039510.txt

## Key facts
- Executive change
  Peter N. Reikes resigned as Director at IONIS PHARMACEUTICALS INC.
  - Action: resigned
  - Role: Director
  source text: On November 19, 2021, Peter N. Reikes, a member of the Board of Directors (“Board”) and Finance Committee of the Board of Ionis Pharmaceuticals, Inc. (the “Company”), notified the Company that he is resigning from the Company’s Board effective November 21, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/874015/000114036121039510/0001140361-21-039510-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.